Page last updated: 2024-09-03

n-benzyladriamycin-14-valerate and Disease Models, Animal

n-benzyladriamycin-14-valerate has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Covey, LR; Edwards, SK; Grewal, S; Liu, Y; Moore, CR; Xie, P1

Other Studies

1 other study(ies) available for n-benzyladriamycin-14-valerate and Disease Models, Animal

ArticleYear
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
    BMC cancer, 2013, Oct-16, Volume: 13

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Disease Models, Animal; Diterpenes; Doxorubicin; Enzyme Activation; Gene Expression; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Isografts; Lentivirus; Lymphoma, B-Cell; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Multiple Myeloma; Protein Kinase C-delta; Protein Transport; Proteolysis; Proto-Oncogene Proteins c-myc; TNF Receptor-Associated Factor 3; Transduction, Genetic

2013